Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial

Faster, Cleaner, Better.

GT Biopharma Inc (GTBP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2015	12-2014	12-2013	12-2012	12-2011
Assets
Current Assets
Cash & Cash Equivalents	47	855	43	123	92
Receivables	N/A	N/A	40	N/A	N/A
Inventories	N/A	N/A	42	59	12
TOTAL	$49	$882	$125	$202	$104

Non-Current Assets
PPE Net	5	6	N/A	N/A	N/A
Intangibles	0	0	22	24	25
TOTAL	$5	$6	$22	$24	$25

Total Assets	$54	$888	$147	$226	$129

Liabilities
Current Liabilities
Short Term Debt	7,859	1,754	1,614	1,088	1,770
Accounts payable and accrued liabilities	893	412	940	878	806
Accrued Expenses	6,717	5,110	2,844	2,426	2,205
Other current liabilities	33,266	21,581	109	1,378	158
TOTAL	$49,909	$29,828	$6,384	$6,562	$5,230

Non-Current Liabilities
Long Term Debt	714	634	97	N/A	N/A
TOTAL	$714	$634	$97	$N/A	$N/A

Total Liabilities	$50,623	$30,462	$6,481	$6,562	$5,230

Shareholders' Equity
Shares Outstanding, K	42	599,915	591,715	591,715	300,300
Common Shares	2	2	574	501	269
Retained earnings	-134,417	-112,956	-89,467	-88,966	-83,795
Other shareholders' equity	-166	-166	-150	-87	3
TOTAL	$-50,569	$-29,574	$-6,334	$-6,336	$-5,101

Total Liabilities And Equity	$54	$888	$147	$226	$129